CONCLUSIONS
SARS-CoV-2 has major implications for the cardiovascular system. Given
the decrease in new Covid-19 cases worldwide, now we are approaching the
so-called “Phase 2” challenge of a gradual return to pre-Covid-19
life. The epidemiological and clinical situation is rapidly evolving and
practice patterns with policies depend on institutions and local
availability. We expect a continue and progressive update of the
recommendations, which serve as general framework in cardiac patients.
1. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal
outcomes of patients with coronavirus disease 2019 (COVID-19).JAMA Cardiol . 2020. doi:10.1001/jamacardio.2020.1017
2. Stefanini GG, Azzolini E, Condorelli G. Critical organizational
issues for cardiologists in the COVID-19 outbreak: A frontline
experience from Milan, Italy. Circulation . 2020.
doi:10.1161/circulationaha.120.047070
3. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19.N Engl J Med . 2020. doi:10.1056/NEJMp2003539
4. ESC guidance for the diagnosis and management of CV disease during
the COVID-19 pandemic.
https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance
5. ASE Statement on COVID-19.
https://www.asecho.org/ase-statement-covid-19/